What Joint Commission’s AI Certification Means for HTM
As AI becomes more common across healthcare technology, the voluntary certification gives hospitals a way to demonstrate they have processes in place to govern its use.
As AI becomes more common across healthcare technology, the voluntary certification gives hospitals a way to demonstrate they have processes in place to govern its use.
The technology is no longer a standalone tool, but connective tissue linking devices, data, and clinical workflows.
The partnership between the Food and Drug Administration and the Medicines and Healthcare products Regulatory Agency aims to streamline technology access and reduce regulatory duplication.
As AI becomes more common across healthcare technology, the voluntary certification gives hospitals a way to demonstrate they have processes in place to govern its use.
New guidance permits the use of de-identified data without requiring individual patient information in marketing submissions.
Read MoreFrom advanced scanners to adaptive AI workflows, RSNA 2025 exhibitors debuted imaging tools aimed at personalizing care and improving efficiency.
Read MoreNew guidance aims to clarify cybersecurity roles and expectations between health delivery organizations and medical device manufacturers.
Read MoreThe tool automatically tracks transcatheter repair devices and merges echo and X-ray for clearer intra-procedural guidance.
Read MoreThe software is intended to help manufacturers demonstrate cybersecurity maturity as expectations from regulators and hospital purchasers continue to rise.
Read MoreThe clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
Read More
The postmarket trial is designed to evaluate the performance of a surgical robotic system in free flap reconstruction and lymphatic repair procedures.